NASDAQ:CPRX

Catalyst Pharmaceuticals Stock Forecast

etoro logo Buy CPRX
*Your capital is at risk
$31.34
+0 (+0%)
At Close: Jun 10, 2026
AI Analysis AI Analysis of CPRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CPRX to Watchlist?
Some Reasons Why To Add CPRX:
  • High gross margin of 82.3%
  • Strong operating margin of 44.8%
  • Low bankruptcy risk (Altman Z-Score: 19.86)
PDF

Catalyst Pharmaceuticals stock downgraded from Buy Candidate to Hold/Accumulate after Wednesday trading session
(Updated on Jun 10, 2026)

Buy or Hold candidate since Apr 13, 2026 Gain 23.68%

No changes to the price of Catalyst Pharmaceuticals stock on the last trading day (Wednesday, 10th Jun 2026). During the last trading day the stock fluctuated 0.128% from a day low at $31.33 to a day high of $31.37. The price has risen in 5 of the last 10 days and is up by 0.06% over the past 2 weeks.

The stock has broken the strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $31.93. A reaction back to this level may hold a second chance to get out before further falls.

CPRX Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Tuesday, June 09, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days. The Catalyst Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $31.30 and $30.43. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Catalyst Pharmaceuticals stock

Catalyst Pharmaceuticals finds support from accumulated volume at $31.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0400 between high and low, or 0.128%. For the last week the stock has had daily average volatility of 0.121%.

Our recommended stop-loss: $29.49 (-5.90%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CPRX) For The Upcoming Trading Day Of Thursday 11th

For the upcoming trading day on Thursday, 11th we expect Catalyst Pharmaceuticals to open at $31.35, and during the day (based on 14 day Average True Range), to move between $31.21 and $31.47, which gives a possible trading interval of +/-$0.253 (+/-0.81%) up or down from last closing price. If Catalyst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 0.81% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $31.17, some $0.175 (0.56%) from the current price of $31.34, our system finds the risk reward attractive.

Is Catalyst Pharmaceuticals stock A Buy?

Catalyst Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.939 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 11, 2026 - $31.35 ( 0.0213%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CPRX Performance

Trading levels for CPRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 31.39 0.149%
R2 31.37 0.100%
R1 31.36 0.0700%
Price 31.34
S1 31.33 -0.0275%
S2 31.32 -0.0576%
S3 31.31 -0.106%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 31.34
S1 31.17 -0.558%
S2 31.15 -0.606%
S3 29.27 -6.60%

FAQ

What is the symbol for Catalyst Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Catalyst Pharmaceuticals is CPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Catalyst Pharmaceuticals Stock?
Catalyst Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Catalyst Pharmaceuticals Stock?
Catalyst Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Catalyst Pharmaceuticals Stock.

What's the current price of Catalyst Pharmaceuticals Stock?
As of the end of day on the Jun 10, 2026, the price of an Catalyst Pharmaceuticals (CPRX) share was $31.34.

What is the 52-week high and low for Catalyst Pharmaceuticals Stock?
The 52-week high for Catalyst Pharmaceuticals Stock is $32.56 and the 52-week low is $19.05.

What is the market capitalization of Catalyst Pharmaceuticals Stock?
As of the Jun 10, 2026, the market capitalization of Catalyst Pharmaceuticals is 3.835B.

When is the next earnings date for Catalyst Pharmaceuticals?
The upcoming earnings date for Catalyst Pharmaceuticals is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT CATALYST PHARMACEUTICALS
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
4.95% Jun 05
TPR
$140.47
0.320% Jun 04
N
NVRI
$19.53
4.92% May 20
GLBE
$31.61
3.54% May 05
FIZZ
$34.11
8.80% May 01

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE